Testing effectiveness (Phase 2)Study completedNCT00443326What this trial is testingAMG 714 20060349 Multiple Dose Study in Moderate to Severe Psoriasis SubjectsWho this might be right forPsoriasis Amgen 22
Large-scale testing (Phase 3)Study completedNCT00237887What this trial is testingEfficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic Plaque PsoriasisWho this might be right forPsoriasis Abbott 1,212
Early research (Phase 1)Study completedNCT07051538What this trial is testingA Phase I Clinical Trial of Single Subcutaneous Injection or Intravenous Infusion of SHR-1139 Injection in Healthy Chinese Subjects and Multiple Subcutaneous Injections in Patients With Moderate-to-severe Plaque PsoriasisWho this might be right forModerate to Severe Plaque Psoriasis Guangdong Hengrui Pharmaceutical Co., Ltd 64
Large-scale testing (Phase 3)Study completedNCT03478787What this trial is testingRisankizumab Versus Secukinumab for Participants With Moderate to Severe Plaque PsoriasisWho this might be right forPsoriasis AbbVie 327
Testing effectiveness (Phase 2)Ended earlyNCT01704599What this trial is testingAddition of Modulators of Homocysteine to Adalimumab Therapy in the Treatment of Moderate to Severe Plaque PsoriasisWho this might be right forPsoriasis Wayne State University 8
Large-scale testing (Phase 3)Study completedNCT05020249What this trial is testingEvaluate the Efficacy and Safety of Bimekizumab in Adult Korean Study Participants With Moderate to Severe Plaque PsoriasisWho this might be right forModerate to Severe Plaque Psoriasis UCB Biopharma SRL 47
Testing effectiveness (Phase 2)Temporarily pausedNCT04121143What this trial is testingA Clinical Study of SHR-1314 Injection in the Treatment of Moderate to Severe Plaque Psoriasis in AdultsWho this might be right forPlaque Psoriasis Jiangsu HengRui Medicine Co., Ltd. 120
Large-scale testing (Phase 3)Study completedNCT00442650What this trial is testingEfalizumab for Treatment of Patients With Moderate to Severe PsoriasisWho this might be right forModerate to Severe Psoriasis Merck KGaA, Darmstadt, Germany
Post-approval studies (Phase 4)Study completedNCT00312026What this trial is testingEvaluate the Safety and Efficacy of Efalizumab in Adult Patients With Plaque Psoriasis Involving the Hands and/or FeetWho this might be right forPsoriasis Genentech, Inc. 75
Large-scale testing (Phase 3)Study completedNCT03210259What this trial is testingThe VOLTAIRE-X Trial Looks at the Effect of Switching Between Humira® and BI 695501 in Patients With Plaque PsoriasisWho this might be right forPsoriasis Boehringer Ingelheim 259
Not applicableLooking for participantsNCT07234591What this trial is testingEvaluate Effectiveness and Safety of a TYK2 Inhibitor in Subjects With Moderate to Severe Plaque PsoriasisWho this might be right forPlaque PsoriasisModerate to Severe Plaque Psoriasis Usynova Pharmaceuticals Ltd. 140
Testing effectiveness (Phase 2)Study completedNCT01855880What this trial is testingPhase IIa Study of Multiple Doses of AbGn-168H by iv Infusion in Moderate to Severe Chronic Plaque Psoriasis PatientsWho this might be right forModerate to Severe Chronic Plaque Psoriasis AbGenomics B.V Taiwan Branch 54
Not applicableStudy completedNCT00800982What this trial is testingOpen Label Study Etanercept's Maintenance Dose in Obese Patients With Moderate to Severe Plaque Type PsoriasisWho this might be right forPsoriasis University of California, San Francisco 30
Testing effectiveness (Phase 2)Study completedNCT00504270What this trial is testingR3421 in Patients With Moderate to Severe Chronic Plaque Psoriasis.Who this might be right forPsoriasis Hoffmann-La Roche 66
Large-scale testing (Phase 3)Study completedNCT01550744What this trial is testingUstekinumab to Evaluate a "Subject-tailored" Maintenance Dosing Approach in Subjects With Moderate-to-Severe Plaque PsoriasisWho this might be right forPsoriasis Janssen Biotech, Inc. 478
Testing effectiveness (Phase 2)Study completedNCT06542614What this trial is testingTreatment of Moderate to Severe Plaque PsoriasisWho this might be right forPlaque Psoriasis Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. 209
Early research (Phase 1)UnknownNCT05258331What this trial is testingClinical Trial to Evaluate the Safety, Tolerability and Efficacy of CT303 in Patients With PsoriasisWho this might be right forModerate to Severe Plaque Psoriasis GC Cell Corporation 24
Testing effectiveness (Phase 2)Study completedNCT01043393What this trial is testingDesoximetasone Spray 0.25%, Hypothalamic Pituitary Adrenal (HPA) Axis StudyWho this might be right forPsoriasis Sun Pharmaceutical Industries, Inc. 24
Not applicableEnded earlyNCT00402818What this trial is testingRESTORE: Raptiva® (Efalizumab) Evaluation of Safety and Treatment OptimizationWho this might be right forPlaque Psoriasis Merck KGaA, Darmstadt, Germany 294
Large-scale testing (Phase 3)Not Yet RecruitingNCT07362017What this trial is testingOpen Label Study to Investigate the Safety and Efficacy of Ponesimod in Moderate-to-Severe Chronic Plaque PsoriasisWho this might be right forModerate-to-severe Chronic Plaque Psoriasis Vanda Pharmaceuticals 300